Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (2): 231-236    DOI: 10.12891/ceog4101.2018
Original Research Previous articles | Next articles
Application of droplet digital PCR for prenatal screening of Down syndrome
Manwu Wu1, *(), Zhihao Yang1, Xinzhong Yu1, Feiyan Qian1, Lei Qian1, Wei Li2
1 Department of Laboratory Genetics, Shaoxing Women and Children’s Hospital, Shaoxing, Zhejiang, China
2 School of Laboratory Medicine and Life Science, Medical University,Wenzhou, Zhejiang, China
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: This study was proposed to explore the feasibility of droplet digital PCR (ddPCR) analysis for non-invasive prenatal diagnosis of Down syndrome. Materials and Methods: The authors studied maternal plasma samples from 465 pregnant women carrying euploid and trisomy 21 (T21) fetuses. A methylation-sensitive restriction endonuclease, BstUI, was used to digest the hypomethylated holocarboxylase synthetase (HLCS) gene. The authors quantified digestion-resistant HLCS gene on chromosome 21 and fetal-specific rs6636 SNP allele on chromosome 14 by droplet digital PCR analysis. Maternal plasma DNA analysis was performed by comparing the ratio of hypermethylated HLCS to fetal-specific rs6636 SNP allele between two groups. Results: Using a rs6636 SNP allele on chromosome 14 as the reference marker, the authors analyzed 78 euploid and 28 T21 plasma samples. The ratios of the numbers of positive hypermethylated HLCS and the fetal-specific C allele in the euploid and T21 samples were significantly different ( p < 0.01, Mann–Whitney rank sum test), all but two samples with the fetal-specific C allele were correctly classified, while the ratios of the numbers of positive hypermethylated HLCS and the fetal-specific G allele in the euploid and T21 samples were significantly different (p < 0.01, Mann–Whitney rank sum test); all but one sample with the fetal-specific C allele were correctly classified. Conclusions: The study demonstrated that ddPCR approach can be applied for prenatal screening of trisomy 21.
Key words:  Down syndrome      ddPCR      HLCS      qPCR      cffDNA     
Published:  10 April 2018     
*Corresponding Author(s):  MANWU WU     E-mail:  wumanwu1024@163.com

Cite this article: 

Manwu Wu, Zhihao Yang, Xinzhong Yu, Feiyan Qian, Lei Qian, Wei Li. Application of droplet digital PCR for prenatal screening of Down syndrome. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 231-236.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4101.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I2/231

[1] I. H. Kalelioglu, S. G. Erzincan, R. Has, A. Yuksel. Forehead and facial heights in Down syndrome and normal fetuses in the midtrimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 220-227.
[2] Y. Duan, Y. Li, Q. Xue. Serological prenatal screening and diagnosis for Down syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 572-574.
[3] I. H. Kalelioğlu. Humerus length measurement in Down syndrome screening[J]. Clinical and Experimental Obstetrics & Gynecology, 2007, 34(2): 93-95.
No Suggested Reading articles found!